NASA in nasal spray deal to combat motion sickness

CAPE CANAVERAL, Florida Sat Oct 13, 2012 2:26am IST

Related Topics

CAPE CANAVERAL, Florida (Reuters) - NASA has signed an agreement with a California-based startup to develop and market a nasal spray for motion sickness, the U.S. space agency said on Friday.

NASA will work with privately owned Epiomed Therapeutics of Irvine, California, on the nasal spray, which has been shown to be a fast-acting treatment for motion sickness.

About half the astronauts who fly in space develop space motion sickness, with symptoms that anyone nauseated or light-headed from more terrestrial forms of travel will recognize.

NASA has been working on giving astronauts an edge: a fast-acting medicine called intranasal scopolamine, or INSCOP. The drug also can be administered as a tablet, via a transdermal patch or injected, but a nasal spray can work faster and more reliably, NASA said.

"NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness," NASA researcher Lakshmi Putcha, with the Johnson Space Center in Houston, said in a statement.

In addition to partnering with NASA, Epiomed is working with the U.S. Navy to test the nasal spray.

Epiomed will assume responsibility for sponsorship of future clinical trials and for Federal Drug Administration approvals, NASA said. There has been no word on whether a prescription would be required for the nasal spray.

(Editing by Tom Brown, Gary Hill)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Interview

REUTERS SHOWCASE

No Relief

No Relief

Paracetamol no better than placebo for low back pain, study finds.  Full Article 

Fighting AIDS

Fighting AIDS

Bill Clinton says AIDS-free generation 'within reach'.  Full Article 

Obamacare Enrollment

Obamacare Enrollment

Over 10 million U.S. adults gain coverage under Obamacare: study.  Full Article 

Quality Issue

Quality Issue

Ipca halts U.S. shipments from Ratlam plant after FDA finds violations.  Full Article 

Financial Cost

Financial Cost

Abuse of U.S. generic-drug rules costs billions: report.  Full Article 

Fitness Hooping

Fitness Hooping

Hoopsters put circus-inspired spin on cardio workout.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage